The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis

PLoS Pathogens

Volumn 12, Issue 10, 2016, Pages

  Kirchdoerfer, Robert N ^a   Moyer, Crystal L ^a   Abelson, Dafna M ^a,b   Saphire, Erica Ollmann ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Mapp Biopharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; PROTEIN VP30; UNCLASSIFIED DRUG; VIRUS PHOSPHOPROTEIN; TRANSCRIPTION FACTOR; VIRAL PROTEIN; VIRUS RNA; VP30 PROTEIN, EBOLA VIRUS;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTALLIZATION; EBOLAVIRUS; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; ISOTHERMAL TITRATION CALORIMETRY; MUTATION; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SEQUENCE ALIGNMENT; VIRUS REPLICATION; BIOSYNTHESIS; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSCRIPTION; GENETICS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; EBOLAVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; NUCLEOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84992738137     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005937     Document Type: Article

References (42)

1. Ebola virus disease: World Heath Oranization; [cited 2016]. Available from: www.who.int.
2. Ebola Situation Report—30 March 2016: World Health Organization; [cited 2016]. Available from: www.who.int.
3. Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S, Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. Journal of virology. 1999;73(3):2333–42. 9971816
4. Weik M, Modrof J, Klenk HD, Becker S, Muhlberger E, Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. Journal of virology. 2002;76(17):8532–9. doi: 10.1128/jvi.76.17.8532-8539.200212163572
5. Martinez MJ, Biedenkopf N, Volchkova V, Hartlieb B, Alazard-Dany N, Reynard O, et al. Role of Ebola virus VP30 in transcription reinitiation. Journal of virology. 2008;82(24):12569–73. doi: 10.1128/JVI.01395-0818829754
6. Biedenkopf N, Hartlieb B, Hoenen T, Becker S, Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication. The Journal of biological chemistry. 2013;288(16):11165–74. doi: 10.1074/jbc.M113.46128523493393
7. Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE, Role of VP30 phosphorylation in the Ebola virus replication cycle. The Journal of infectious diseases. 2011;204Suppl 3:S934–40. doi: 10.1093/infdis/jir32021987772
8. Modrof J, Moritz C, Kolesnikova L, Konakova T, Hartlieb B, Randolf A, et al. Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. Virology. 2001;287(1):171–82. doi: 10.1006/viro.2001.102711504552
9. John SP, Wang T, Steffen S, Longhi S, Schmaljohn CS, Jonsson CB, Ebola virus VP30 is an RNA binding protein. Journal of virology. 2007;81(17):8967–76. doi: 10.1128/JVI.02523-0617567691
10. Modrof J, Becker S, Muhlberger E, Ebola virus transcription activator VP30 is a zinc-binding protein. Journal of virology. 2003;77(5):3334–8. doi: 10.1128/jvi.77.5.3334-3338.200312584359
11. Hartlieb B, Muziol T, Weissenhorn W, Becker S, Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(2):624–9. doi: 10.1073/pnas.060673010417202263
12. Clifton MC, Kirchdoerfer RN, Atkins K, Abendroth J, Raymond A, Grice R, et al. Structure of the Reston ebolavirus VP30 C-terminal domain. Acta crystallographica Section F, Structural biology communications. 2014;70(Pt 4):457–60. doi: 10.1107/S2053230X1400381124699737
13. Elliott LH, Kiley MP, McCormick JB, Descriptive analysis of Ebola virus proteins. Virology. 1985;147(1):169–76. doi: 10.1016/0042-6822(85)90236-34060597
14. Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, Hoenen T, et al. The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus research. 2009;140(1–2):8–14. doi: 10.1016/j.virusres.2008.10.01719041915
15. Schlereth J, Grunweller A, Biedenkopf N, Becker S, Hartmann RK, RNA binding specificity of Ebola virus transcription factor VP30. RNA biology. 2016:1–16. doi: 10.1080/15476286.2016.119416027315567
16. Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO, Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35Complex. Cell reports. 2015;12(1):140–9. doi: 10.1016/j.celrep.2015.06.00326119732
17. Watanabe S, Noda T, Kawaoka Y, Functional mapping of the nucleoprotein of Ebola virus. Journal of virology. 2006;80(8):3743–51. doi: 10.1128/JVI.80.8.3743-3751.200616571791
18. Dziubanska PJ, Derewenda U, Ellena JF, Engel DA, Derewenda ZS, The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein. Acta crystallographica Section D, Biological crystallography. 2014;70(Pt 9):2420–9. doi: 10.1107/S139900471401471025195755
19. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular systems biology. 2011;7:539. doi: 10.1038/msb.2011.7521988835
20. Jasenosky LD, Neumann G, Kawaoka Y, Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription. Antimicrobial agents and chemotherapy. 2010;54(7):3007–10. doi: 10.1128/AAC.00138-1020421407
21. Leung DW, Borek D, Luthra P, Binning JM, Anantpadma M, Liu G, et al. An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell reports. 2015;11(3):376–89. doi: 10.1016/j.celrep.2015.03.03425865894
22. Noda T, Hagiwara K, Sagara H, Kawaoka Y, Characterization of the Ebola virus nucleoprotein-RNA complex. The Journal of general virology. 2010;91(Pt 6):1478–83. doi: 10.1099/vir.0.019794-020164259
23. Spolar RS, Ha JH, Record MT, Jr.Hydrophobic effect in protein folding and other noncovalent processes involving proteins. Proceedings of the National Academy of Sciences of the United States of America. 1989;86(21):8382–5. doi: 10.1073/pnas.86.21.83822813394
24. Spolar RS, Record MT, Jr.Coupling of local folding to site-specific binding of proteins to DNA. Science (New York, NY). 1994;263(5148):777–84. doi: 10.1126/science.83032948303294
25. Jones DT, Cozzetto D, DISOPRED3: precise disordered region predictions with annotated protein-binding activity. Bioinformatics (Oxford, England). 2015;31(6):857–63. doi: 10.1093/bioinformatics/btu74425391399
26. Clifton M, Lukacs C, Abendroth J, Lorimer D, Edwards T. Structure of minor nucleoprotein V30 from Zaire ebolavirus. 2015. PDB ID: 5DVW.
27. Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.5. 2015
28. Cox R, Pickar A, Qiu S, Tsao J, Rodenburg C, Dokland T, et al. Structural studies on the authentic mumps virus nucleocapsid showing uncoiling by the phosphoprotein. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(42):15208–13. doi: 10.1073/pnas.141326811125288750
29. Green TJ, Luo M, Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(28):11713–8. doi: 10.1073/pnas.090322810619571006
30. Reid SP, Cardenas WB, Basler CF, Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology. 2005;341(2):179–89. doi: 10.1016/j.virol.2005.06.04416095644
31. Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, et al. Inclusion bodies are a site of ebolavirus replication. Journal of virology. 2012;86(21):11779–88. doi: 10.1128/JVI.01525-1222915810
32. Nanbo A, Watanabe S, Halfmann P, Kawaoka Y, The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Scientific reports. 2013;3:1206. doi: 10.1038/srep0120623383374
33. Becker S, Rinne C, Hofsass U, Klenk HD, Muhlberger E, Interactions of Marburg virus nucleocapsid proteins. Virology. 1998;249(2):406–17. doi: 10.1006/viro.1998.93289791031
34. Yabukarski F, Lawrence P, Tarbouriech N, Bourhis JM, Delaforge E, Jensen MR, et al. Structure of Nipah virus unassembled nucleoprotein in complex with its viral chaperone. Nature structural & molecular biology. 2014;21(9):754–9. doi: 10.1038/nsmb.286825108352
35. Hoenen T, Jung S, Herwig A, Groseth A, Becker S, Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology. 2010;403(1):56–66. doi: 10.1016/j.virol.2010.04.00220444481
36. Kabsch W, XDS. Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 2):125–32. doi: 10.1107/S090744490904733720124692
37. Evans P, Scaling and assessment of data quality. Acta crystallographica Section D, Biological crystallography. 2006;62(Pt 1):72–82. doi: 10.1107/s090744490503669316369096
38. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ, Phaser crystallographic software. Journal of applied crystallography. 2007;40(Pt 4):658–74. 19461840
39. Emsley P, Lohkamp B, Scott WG, Cowtan K, Features and development of Coot. Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 4):486–501. doi: 10.1107/S090744491000749320383002
40. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 2):213–21. doi: 10.1107/S090744490905292520124702
41. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta crystallographica Section D, Biological crystallography. 2011;67(Pt 4):355–67. doi: 10.1107/S090744491100131421460454
42. Krissinel E, Henrick K, Inference of macromolecular assemblies from crystalline state. Journal of molecular biology. 2007;372(3):774–97. doi: 10.1016/j.jmb.2007.05.02217681537